23andMe to Be Bought by Regeneron Pharmaceuticals, a Biotech...

shared a link to vibe with.

2025-05-19 21:17:12 -

WWW.NYTIMES.COM

23andMe to Be Bought by Regeneron Pharmaceuticals, a Biotech Company, for $256 Million

Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer consumer DNA testing services.

0 Commentarios 0 Acciones 90 Views 0 Vista previa